SeaStar Medical is trading at $4.00 (+16.28%) in pre-market after a sharp gap higher from its previous close of $3.44.
- The move comes despite a lack of company-specific announcements, earnings releases, or FDA updates in available sources.
- The stock appears to be benefiting from a stronger healthcare sector tone, with the XLV up 2.94% in pre-market trading.
- The specific catalyst for the outsized move remains unclear, suggesting the price action may be amplified by thin pre-market liquidity.